Posted by Michael Wonder on 02 May 2022
TLV submits proposals for increased access to new gene therapies
2 May 2022 - How should society handle new gene therapies for serious diseases, where the effect of the drugs is uncertain and the cost is very high?
In a report to the government, the Swedish Dental and Pharmaceutical Benefits Agency, TLV, presents proposals for measures that can make it easier for patients to gain access to these medicines.
